No. of views : (11469)
Low-cost diabetes drug to be launched by Glenmark
Posted on: 26/Aug/2015 10:03:22 AM
Generic Teneligliptin, a new third-generation oral anti-diabetic drug will be launched by Glenmark. This will be substantially lower price compared to other Gliptins available in India.
Only 1.05 million out of the 65 million diabetic patients in India use Gliptins as they are relatively expensive costing Rs 15,000-Rs 16,000 a year of treatment while Glenmark thinks the lower price would encourage more patients to adopt this safer and effective treatment to manage Type-2 diabetes.
This product costs Rs 19.90 per tablet compared with about Rs 45 for other gliptins.
